Pacific Ocean - The Nimitz-class aircraft carrier USS Theodore Roosevelt (CVN 71) and the Theodore Roosevelt Carrier Strike Group (TRCSG) entered the U.S. 7th Fleet area of operations (AOO) yesterday, to conduct maritime security operations, theater security cooperation and port visits as part of the U.S. Navy's ongoing presence in the Indo-Asia-Pacific region.

Washington, DC - There are nearly 1.4 million phishing websites created every month, according to the Webroot Quarterly Threat Trends Report (reported on by Dark Reading). This is a substantial increase from the threat report issued last December, which saw 13,000 new phishing sites per day. That extrapolates to 390,000 per month. Nearly a 1,000,000 site increase.

Washington, DC - FDA Commissioner Scott Gottlieb, M.D.: "Enabling patients and providers to have efficient access to new and innovative medical products that meet the FDA’s gold standard for safety and effectiveness is a core part of our mission. We’re advancing these goals as part of the Medical Innovation Access Plan that I announced earlier this year. While we’ve unveiled parts of that plan already, we’ll be releasing its full detail shortly. As one part of that effort, we’re announcing some additional steps we’re taking right now to promote beneficial medical device innovation.

Escondido, California - San Diego Zoo Global researchers will join Northrop Grumman Corporation engineers to announce the continuation of a unique collaboration that addresses critical research questions, to gain a better understanding of the Arctic and current threats to polar bears. Northrop Grumman engineers will showcase custom, innovative technology developed for wildlife research with a flyover demonstration at the San Diego Zoo Safari Park.

Pacific Ocean - The High Mobility Artillery Rocket System (HIMARS) was fired from the flight deck of the San Antonio-class amphibious transport dock ship USS Anchorage (LPD 23) during Dawn Blitz 2017 Yesterday.

Washington, DC - Today the U.S. Food and Drug Administration issued a warning letter to Magellan Diagnostics Inc. for several violations of federal law, including marketing significantly modified versions of two of its blood lead testing systems without the FDA’s required clearance or approval and failing to submit medical device reports to the FDA after becoming aware of customer complaints involving discrepancies in blood lead test results.